Novo Nordisk's GLP-1 drugs have been under considerable competitive pressure in the last few months, so the company will be ...

Less than a year after it was forced to withdraw GBT's sickle cell disease (SCD) therapy Oxbryta from all world markets after ...

In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

At ASCO 2025 in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Dr Jason Williams, director of interventional ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

“Sexuality and intimacy are important aspects of quality of life and may also reduce some of the psychosocial distress ...

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

Confirmation of that has come in the form of an update (PDF) from the New Jersey Department of Labour and Workforce ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease ...